PTC Therapeutics | PTCT - Loan Capital

Stock Price
68.09
Daily Change
0.33 0.49%
Monthly
-9.80%
Yearly
34.65%
Q1 Forecast
68.47

PTC Therapeutics reported $2.03B in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
Acadia Pharmaceuticals USD 0 0 Mar/2025
Alnylam Pharmaceuticals USD 2.48B 1.44B Dec/2025
Amgen USD 50B 2.43B Dec/2025
BioCryst Pharmaceuticals USD 194.37M 48.43M Sep/2025
Biogen USD 6.29B 1.4M Sep/2025
BioMarin Pharmaceutical USD 597.18M 513K Dec/2025
Cytokinetics USD 1.12B 957.23M Dec/2025
Daiichi Sankyo JPY 300.15B 199.41B Dec/2025
Enanta Pharmaceuticals USD 0 0 Dec/2024
Esperion Therapeutics USD 262.48M 235.95M Jun/2024
Gilead Sciences USD 22.14B 5M Sep/2025
Incyte USD 30.2M 5.17M Dec/2025
Ionis Pharmaceuticals USD 1.9B 1.87B Dec/2025
Ironwood Pharmaceuticals USD 583.99M 14.83M Dec/2024
Karyopharm Therapeutics USD -0.93 0.67 Dec/2024
Novartis USD 24.24B 174M Sep/2025
Pfizer USD 57.41B 93M Sep/2025
PTC Therapeutics USD 2.03B 193.22M Dec/2025
Puma Biotechnology USD 10.87M 222K Jun/2025
Roche Holding CHF 27.43B 966M Dec/2025
Sangamo BioSciences USD 0 0 Jun/2022
Sarepta Therapeutics USD 828.97M 206.17M Dec/2025
TG Therapeutics USD 245.34M 303K Sep/2025
Ultragenyx Pharmaceutical USD 763.74M 19.02M Sep/2025
Vertex Pharmaceuticals USD 111.4M 1.4M Mar/2025
Xencor USD 76.48M 11.29M Dec/2025